NL-OMON28328已完成不适用
Short term effect of oral risedronate on markers of bone formation and resorption in patients with alkaptonuria.
MC Utrecht0 个研究点目标入组 6 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 6
研究概览
简要总结
/A
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1. Patients with alkaptonuria;
- •2. Osteopenia or osteoporose on DEXA-scan;
排除标准
- •1. Short life expectancy;
- •2. Hepatic or renal disease;
研究者
相似试验
已完成
不适用
Effects of risedronate on the progression of aortic valv stenosis in osteoporosis patientsAortic valve stenosis with osteoporosisJPRN-UMIN000003226Juntendo University School of Medcine, The department of Cardiology180
已完成
不适用
Study on preventive effect of risedronate administration on aromatase inhibitor-induced bone mineral loss in the endoclinical therapy for postmenopausal breast cancer patientsHormone-receptor positive, postmenopausal primary breast cancerJPRN-UMIN000004375Graduate School of Medicine Kyoto University64
进行中（未招募）
不适用
Effects of generic risedronate on bone turnover markers and bone mineral density in Thai postmenopausal osteoporosis.postmenopausal womenBone turnover markersrisedronateBMDosteoporosisTCTR20240427002Ratchadapisek Research Funds80
已完成
不适用
Effects of risedronate and alfacalcidol on parameters of atherosclerosis in type 2 diabetes patients with osteoporosisType 2 diabetes with osteoporosisJPRN-UMIN000001992Department of Internal Medicine 1, Shimane University School of Medicine40
已完成
不适用
Randomized phase II/III study of Risedronate in combination with Docetaxel versus Docetaxel alone in patients with hormone refractory prostate cancer.NL-OMON22637ot applicable480